Delivering News That Matters

Will an Apple a day keep Micro$oft away? Will Facebook outpace MySpace in the war for social networking advertising dollars? And what is Google doing to blow away the Yahooligans? Read our wired-in reporters coverage of the industry that was once thought of as the darling of the baby boomers but now captures the attention of the Gen-Xers. Stop by daily for a dose of HWS insight about innovations in emerging tech stocks.

Green Street Capital Corporation Announces Name Change and Reverse Stock Split


ORLANDO, FL–(Marketwire – 07/16/10) – Green Street Capital Corporation, formerly Jaguar Mining Enterprises, (Pinksheets:JAGRD – News), announced today that it has received approval from the Financial Industry Regulatory Authority (“FINRA”) clearing the name change and reverse stock split previously approved by its stockholders on May 3, 2010. These corporate actions took effect on July 16, [...]

AlphaRx Regains Rights to Indaflex(TM)


HONG KONG, June 29 /PRNewswire-FirstCall/ – AlphaRx, Inc. (OTCBB:ALRX) today announced that it has entered into an agreement with Cypress Bioscience (Nasdaq:CYPB – News), under which AlphaRx is regaining all rights to Indaflex(TM) from Cypress Bioscience, which AlphaRx had previously licensed to Proprius Pharmaceuticals, which was subsequently acquired by Cypress Bioscience.
“With our Cypress colleagues, we [...]

AlphaRx Plans to List Subsidiary


Companies need to periodically consider actions that unlock their intrinsic value. At this point in time, AlphaRx is pursuing such an opportunity.
Hong Kong, March 29, 2010 (MARKETWIRE) — AlphaRx, Inc. (OTCBB: ALRX) today announced that the Company plans to list its’ Canadian subsidiary, which has been focused on China and emerging markets, on a Canadian [...]

ARCA biopharma Announces Patent Issued for Treating Heart Failure Patients with Bucindolol Based on Genetic Testing


Revised Request for FDA Special Protocol Assessment for GencaroTM Development in Genotype-defined Heart Failure Population Submitted
ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company developing genetically targeted therapies for heart failure and other cardiovascular diseases, today announced that the U.S. Patent and Trademark Office (USPTO) has issued a patent on methods of treating heart failure [...]

iTokk Inc. Signs Letter of Intent (LOI) With Pantum International B.V., of The Netherlands


2010-02-02 09:00 ET – News Release
iTokk Inc. (OTCBB: IKTO) iTokk Inc. announced today from its offices in London, England, that it signed a Letter of Intent (LOI) for a strategic distribution partnership with Pantum International B.V. of The Netherlands. Pantum International is a global provider of new surplus and [...]

AlphaRx and Gaia BioPharma Secure Phase I/II Manufacturer for GAI-122 and Unveil Their Clinical Development Strategy


HONG KONG — (MARKET WIRE) — 01/21/10 AlphaRx Inc. (OTCBB: ALRX) announced today that its licensee, Gaia BioPharma Limited, has signed an agreement with a contract manufacturing organization (CMO) to manufacture GAI-122 for use in the planned Phase I and II clinical trials of that product candidate. GAI-122 is being developed as I.V. administered formulation [...]

AlphaRX – Review January 2010


After trading as high as $0.19 late last July the stock traded down to $0.07 on Dec. 7. During the dying days of 2009 the stock has traded wildly in a $0.075 to $0.16 range and closed out the year at $0.12. As much as I would like to offer a definitive opinion on [...]

Page 1 of 41234